Articles > Reference > Encyclopedias, Almanacs, Transcripts, and Maps > The Mosby Medical Encyclopedia entries

Article: neuromuscular blocking agent

Article from:
The Mosby Medical Encyclopedia
Copyright

The Mosby Medical Encyclopedia
10-01-1996
neuromuscular blocking agent, a drug that interferes with the sending or receiving of signals from motor nerves to skeletal muscles. Neuromuscular blocking agents are used to cause muscles to relax in anesthesia, to aid putting an airway tube into the throat, in electroshock therapy, and in treating tetanus, encephalitis, and poliomyelitis. Neuromuscular blocking drugs can cause spasm of the bronchial tubes, very high body ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: GLAXO WELLCOME RECEIVES MARKETING CLEARANCE FOR A UNIQUE ...
PR Newswire;  December 20, 1995 ;     700+ words ... ... intermediate-duration neuromuscular blocking agent used during general anesthesia ... Nimbex is the fifth neuromuscular blocking agent to be developed and marketed ... Other Glaxo Wellcome neuromuscular blocking agents are Anectine ...

Article: Ohmeda expands anesthesia-related offerings with new ...
Business Wire;  March 18, 1997 ;     700+ words ... ... approved atracurium besylate injection, a neuromuscular blocking agent, for marketing by Ohmeda, a global market ... besylate injection is an intermediate-duration neuromuscular blocking agent used during general anesthesia to facilitate ...

Article: Unintentional Neuromuscular Blocking Agent ...
Regional Anesthesia and Pain Medicine;  January 1, 2005 ;     700+ words ... ... techniques.1-6 To the best of our knowledge, administration of atracurium, a highly selective competitive neuromuscular blocking agent, during peripheral nerve block has never been reported. We describe the unintentional injection of 50 mg ...

Article: Neuromuscular blocking agents: enhancing safety by ...
Dynamics;  March 22, 2007 ;     700+ words ... ... inadvertent administration of neuromuscular blocking agents Critical care ... administered 5 mL of the neuromuscular blocking agent instead of heparin ... vecuronium, she removed the neuromuscular blocking agent from the cabinet and ...

Article: Protocol for use of nondepolarizing neuromuscular ...
Formulary;  February 1, 1998 ;     480 words ... ... Hospital, Detroit-Neuromuscular blocking agents differ in their ... patients receiving neuromuscular blocking agents must also receive ... of nondepolarizing neuromuscular blocking agents in mechanically ...

Article: Neuromuscular blocking drugs often administered to ...
Heart Disease Weekly;  February 16, 2003 ;     626 words ... ... States, "Available data suggest that the choice of neuromuscular blocking drugs (NMBDs) can influence early clinical recovery ... their study in Anesthesia and Analgesia (The use of neuromuscular blocking drugs in adult cardiac surgery: Results of a national ...

Article: Masseter muscle rigidity and nondepolarizing neuromuscular ...
Mayo Clinic Proceedings;  April 1, 1997 ;     700+ words ... ... NAMHR) was searched for previously reported cases of MMR related to the administration of nondepolarizing neuromuscular blocking agents. At our request, the NAMHR was cross-referenced for cases that involved MMR and the administration ...

Article: Ipsen and Medicis Announce Submission of Reloxin(R) in Aesthetics ...
Business Wire;  December 6, 2007 ;     700+ words ... ... for the product in certain additional key international markets. Dysport([R]) is a neuromuscular blocking agent which acts as a neuromuscular blocking toxin, which was initially developed for the treatment of motor disorders and various ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives